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Maintenance of endothelial barrier function 
and establishing its set point in vascular in-
flammation  plays  a  critical  role  in  vascular 
homeostasis  (Dejana,  2004;  Aird,  2007;   
Lampugnani and Dejana, 2007). The endo-
thelial monolayer controls the transvascular 
flux  of  fluid,  proteins,  and  cells  across  the 
vessel  wall  into  underlying  tissues  (Dejana   
et al., 2008). Although small increases in en-
dothelial permeability such as those induced 
by  vascular  endothelial  growth  factor  are 
beneficial  to  normal  organs  because  they   
increase supply of nutrients and oxygen to 
tissues,  severe  loss  of  endothelial  barrier 
function  causes  excessive  build-up  of  fluid 
leading  to  organ  dysfunction  and  chronic   
inflammation (Weis and Cheresh, 2005). In 
such cases, there is a persistent increase in 
endothelial  permeability,  hemorrhage,  leu-
kocyte  transmigration,  and  formation  of   
microthrombi (Mehta and Malik, 2006; Dejana 
et  al.,  2008).  An  uncontrolled  increase  in 
vascular permeability is the hallmark of a va-
riety  of  inflammatory  disorders  including 
acute lung injury (Ware and Matthay, 2000; 
Mehta and Malik, 2006). In this context, it 
would be valuable to have novel approaches 
for the therapeutic control of vascular per-
meability  based  on  the  reannealing  of  the   
endothelial barrier.
Adherens  junctions  (AJs)  play  a  crucial 
role in the regulation of endothelial barrier 
function (Bazzoni and Dejana, 2004; Mehta 
and Malik, 2006). AJs in the endothelium are 
composed  of  vascular  endothelial  cadherin 
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Repair of the injured vascular intima requires a series of coordinated events that mediate 
both endothelial regeneration and reannealing of adherens junctions (AJs) to form a  
restrictive endothelial barrier. The forkhead transcription factor FoxM1 is essential for 
endothelial proliferation after vascular injury. However, little is known about mechanisms 
by which FoxM1 regulates endothelial barrier reannealing. Here, using a mouse model with 
endothelial cell (EC)-restricted disruption of FoxM1 (FoxM1 CKO) and primary cultures of 
ECs with small interfering RNA (siRNA)-mediated knockdown of FoxM1, we demonstrate  
a novel requisite role of FoxM1 in mediating endothelial AJ barrier repair through the  
transcriptional control of -catenin. In the FoxM1 CKO lung vasculature, we observed 
persistent microvessel leakage characterized by impaired reannealing of endothelial AJs 
after endothelial injury. We also showed that FoxM1 directly regulated -catenin tran-
scription and that reexpression of -catenin rescued the defective AJ barrier–reannealing 
phenotype of FoxM1-deficient ECs. Knockdown of -catenin mimicked the phenotype of 
defective barrier recovery seen in FoxM1-deficient ECs. These data demonstrate that 
FoxM1 is required for reannealing of endothelial AJs in order to form a restrictive  
endothelial barrier through transcriptional control of -catenin expression. Therefore, 
means of activating FoxM1-mediated endothelial repair represent a new therapeutic 
strategy for the treatment of inflammatory vascular diseases associated with persistent 
vascular barrier leakiness such as acute lung injury.
© 2010 Mirza et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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RESULTS
Deletion of FoxM1 induces defective endothelial  
barrier recovery in vessels and endothelial monolayers  
after PAR-1 activation
To inactivate FoxM1 in the endothelium, mice carrying a 
FoxM1 gene in which exons 4–7 were flanked by two loxP 
sites were bred with Tie2 promoter/enhancer-driven Cre 
transgenic mice (Zhao et al., 2006). Tie2 promoter/enhancer-
driven Cre expression resulted in EC-restricted disruption 
of FoxM1 (Zhao et al., 2006). Activation of the protease-
activated receptor 1 (PAR-1) by either PAR-1–specific 
activating peptide or thrombin induces endothelial barrier 
dysfunction through disruption of AJs (Coughlin, 2000; 
Vogel et al., 2000; Birukova et al., 2004; Broman et al., 
2006;  Camerer  et  al.,  2006;  Mehta  and  Malik,  2006).   
Using  the  isolated-perfused  lung  model  (Vogel  et  al., 
2000; Tiruppathi et al., 2002; Zhao et al., 2006), we ob-
served  that  the  basal  lung  capillary  filtration  coefficient 
(Kf,c), a measure of vascular permeability, of FoxM1 CKO 
mice  was  similar  to  WT.  In  response  to  PAR-1–specific   
peptide (TFLLRN-NH2), FoxM1 CKO lungs had the same 
increase in Kf,c at 30 min after challenge as the WT. However, 
Kf,c in FoxM1 CKO lungs remained significantly elevated for 
at least 4 h after challenge, whereas Kf,c in WT returned to 
baseline within 2.5 h of PAR-1 activation (Fig. 1), which is 
indicative of impaired reannealing of the endothelial barrier 
in FoxM1 CKO lungs.
To  gain  insights  into  the  mechanism  of  FoxM1  in   
regulating  endothelial  barrier  function,  we  used  small   
(VE-cadherin),  -catenin,  -catenin,  and  p120-catenin 
(Lampugnani et al., 1995; Aberle et al., 1996). Endothelial 
cells (ECs) forming a monolayer adhere to one another by 
a homotypic interaction between the extracellular domains 
of VE-cadherin. VE-cadherin binds -catenin via its cyto-
plasmic domain, which in turn binds the actin-associated 
protein -catenin. -catenin, a member of armadillo repeat 
family of proteins, plays a particularly important role in AJ 
integrity (Cattelino et al., 2003). The interaction of VE- 
cadherin with -catenin determines the stability of cell–
cell junctions, and it is required for control of endothelial 
permeability (Cattelino et al., 2003). Intercellular adhesion 
between  truncated  VE-cadherin  mutants  that  do  not   
bind  to  -catenin  induced  severely  weakened  AJs  and   
resulted  in  fetal  death  in  mice  (Navarro  et  al.,  1995;   
Carmeliet et al., 1999). The cytoplasmic domain of cad-
herins is also unstructured in the absence of -catenin, and 
cadherin binding with -catenin prevented the recogni-
tion of cadherins by degradation pathways (Huber et al., 
2001). Thus, -catenin, an integral component of the en-
dothelial intercellular AJs, is required for normal endothe-
lial barrier function.
Forkhead box M1 (FoxM1) is a member of the fox 
family of transcription factors that share homology in their 
winged helix DNA-binding domains (Clark et al., 1993; 
Kaestner et al., 2000). FoxM1 is a proliferation-associated 
transcription factor that controls both G1/S and G2/M 
phase progression by transcriptional regulation of a set of 
genes essential for cell cycle progression, including the cy-
clin-dependent  kinase  inhibitors  p21Cip1  and  p27Kip1, 
Cdc25A  and  Cdc25B,  Aurora  B  kinase,  and  Polo-like   
kinase 1 (Kalinichenko et al., 2004; Costa, 2005; Laoukili 
et al., 2005; Wang et al., 2005; Wierstra and Alves, 2007). 
FoxM1-null mutation causes embryonic lethality in mice 
due to impaired execution of mitosis (Korver et al., 1998; 
Krupczak-Hollis et al., 2004). We have previously identi-
fied a critical role of FoxM1 in regulating endothelial re-
generation after vascular injury (Zhao et al., 2006). Using 
mutant  mice  with  EC-restricted  disruption  of  FoxM1 
(FoxM1 CKO), we observed that FoxM1 deficiency re-
sulted in defective EC proliferation due to the sustained 
expression of p27Kip1 and decreased expression of cyclins 
and Cdc25C after lung vascular injury induced by lipo-
polysaccharide.  Thus,  FoxM1  CKO  mice  exhibited  se-
verely impaired recovery of endothelial barrier function 
(Zhao et al., 2006). Given the fact that endothelial repair 
requires  endothelial  regeneration  as  well  as  reannealing   
of AJs to form the restrictive endothelial barrier, we ad-
dressed here whether FoxM1 mediates endothelial barrier 
repair by promoting AJ assembly. Thus, we determined the 
role of FoxM1 in mediating the expression of -catenin 
and restoration of endothelial barrier function. Our results 
show that FoxM1 mediates AJ reannealing through the 
transcriptional control of -catenin expression during endothe-
lial repair.
Figure 1.  Impaired reannealing of the endothelial barrier after an 
increase in lung vascular permeability induced by PAR-1 activation 
in FoxM1 CKO mice. FoxM1 CKO mice or WT littermates were treated 
with either saline or a PAR-1 agonist peptide (i.v., 5 mg/kg BW). Lungs 
were isolated at the indicated times and perfused for Kf,c measurements. 
Kf,c was also measured at baseline (time 0). Data are expressed as mean ± 
SD (error bars; n = 3). *, P < 0.05 versus WT/agonist. Agonist, PAR-1 ago-
nist peptide. Three independent experiments were performed with 20 WT 
and 21 FoxM1 CKO mice at the age of 3.5–4 mo old. FoxM1 CKO lungs 
exhibited persistent microvessel leakage after PAR-1 activation.JEM VOL. 207, August 2, 2010 
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3 h (Figs. 2 A and S1). These findings were consistent   
with the data in the previous paragraph in the intact mouse 
lung vessels. We also observed defective recovery of endo-
thelial  barrier  in  FoxM1-deficient  EC  monolayers  after 
challenge with histamine (Fig. S2), which indicates that 
the defective AJ barrier recovery response was not media-
tor specific. Using confocal microscopy, we observed that 
both control and FoxM1-deficient EC monolayers formed 
intact cell–cell junctions at baseline and exhibited similar 
AJ disruption at 20 min after the thrombin challenge (Fig. 3). 
scRNA-transfected HMVEC-L reformed an intact mono-
layer at 120 min after challenge, whereas the defect per-
sisted  up  to  240  min  after  the  thrombin  challenge  in 
siRNA-transfected HMVEC-L (Fig. 3).
interfering RNA (siRNA) to knock down FoxM1 in en-
dothelial monolayers, and measured transendothelial elec-
trical resistance (TER) to quantify time-dependent changes 
in the integrity of endothelial AJs. After transfection with 
either FoxM1 siRNA or scrambled control RNA (scRNA; 
Kalinichenko et al., 2004), human lung microvascular ECs 
(HMVEC-L) were plated at confluent density on gold elec-
trodes to form cell–cell contact and intact monolayers before 
induction of FoxM1 deficiency by siRNA. Mock transfec-
tion of HMVEC-L was also used as a control. At 65 h after 
transfection, the three groups of endothelial monolayers 
exhibited similar basal barrier function assessed by TER 
(Figs. 2 A and S1). Monolayers were then challenged with 
thrombin (4 U/ml), and changes in TER were monitored 
for  3  h.  We  observed  similar  decreases  in  TER  in  all 
groups in response to thrombin (Figs. 2 A and S1), which 
is indicative of similar AJ disruption. However, TER in 
FoxM1 siRNA-transfected cells failed to recover even at 
10 h after the thrombin challenge, whereas scRNA and 
mock-transfected cells had fully recovered TER within   
Figure 2.  Requirement of FoxM1 for reforming a restrictive bar-
rier in ECs after PAR-1 activation. (A) TER assay of endothelial AJ in-
tegrity in response to thrombin challenge (PAR-1 activation). HMVEC-L 
transfected with either human FoxM1 siRNA (siRNA) or scRNA, or mock-
transfected (CTL), were plated to confluency on electrodes. AT 65 h after 
transfection, TER of each monolayer at baseline was recorded, and it was 
then monitored for 3 h after thrombin challenge (4 U/ml). TER values of 
each monolayer were normalized to their values at basal levels. Data are 
expressed as mean ± SD (error bars; n = 3 independent experiments).  
*, P < 0.05 versus either CTL or scRNA. FoxM1 deficiency induced a defec-
tive recovery of the endothelial barrier function after thrombin challenge.  
(B) Western blot analysis demonstrating siRNA-mediated knockdown of 
FoxM1 in HMVEC-L. At 65 h after transfection, HMVEC-L were lysed, and 
15 µg of each lysate per lane was loaded for detection of FoxM1 protein 
level with anti-FoxM1 antibody. The same membrane was blotted with 
anti-actin antibody for loading control. The experiment was performed 
three times with similar results.
Figure 3.  Confocal microscopy of endothelial junctions after PAR-1 
activation. (A) Representative micrographs of anti–VE-cadherin  
staining. After transfection with either human FoxM1 siRNA (siRNA) or 
scRNA, HMVEC-L were plated in 24-well plates with a glass coverslip in 
each chamber at 100% confluency. At 65 h after transfection, the cells 
were treated with 4 U/ml thrombin in triplicate, and fixed with 4%  
paraformaldehyde at the indicated times. The fixed cells were immuno-
stained with anti–VE-cadherin antibody (green) to visualize junctions, and 
nuclei were counterstained with DAPI (blue). FoxM1-deficient HMVEC-L 
(siRNA-transfected) exhibited defective reannealing of AJs at 2 and 4 h 
after thrombin challenge, in contrast to scRNA-transfected controls 
(scRNA). Arrows indicate failure of reannealing of AJs. The experiment 
was performed three times with similar data. Bar, 50 µm. (B) Quantifica-
tion of intercellular AJ gap area. The area of intercellular AJ gaps was 
quantified using MetaMorph 7.1.0 by manually outlining cells and select-
ing for gaps. Values are expressed as the percentage of total surface area. 
Data are expressed as mean ± SD (error bars; n = 3 independent  
experiments). *, P < 0.05 versus scRNA at 120 and 240 min  
after thrombin challenge.1678 FoxM1 regulates endothelial AJ re-annealing | Mirza et al.
blot analysis demonstrated markedly decreased basal -catenin 
protein expression in FoxM1-deficient HMVEC-L as well as 
after  the  thrombin  challenge,  whereas  protein  levels  of 
other AJ components—VE-cadherin, -catenin, and p120-
catenin—were unchanged (Fig. 4, B and C). As shown in 
Fig. 4 (D and E), -catenin expression in the membrane   
fraction  was  markedly  decreased  basally  in  confluent   
FoxM1-deficient  HMVEC-L,  whereas  the  cytosolic   
-catenin fraction did not change. After the thrombin chal-
lenge, -catenin membrane expression was decreased in both 
scRNA- and siRNA-treated cells at 20 min, and its cytosolic 
expression was increased. -catenin membrane and cytosolic 
expression returned to basal levels at 2 h after the thrombin 
challenge in scRNA-treated HMVEC-L, but not in the FoxM1-
deficient cells (Fig. 4, D and E).
Decreased -catenin expression is responsible for defective 
AJ reannealing
To address the role of decreased expression of -catenin in 
mediating defective reannealing of AJs in FoxM1-deficient 
EC monolayers, plasmid DNA expressing -catenin was 
transfected into HMVEC-L along with FoxM1 siRNA, and 
TER was measured to monitor the endothelial integrity.   
Re-expression of -catenin in FoxM1-deficient HMVEC-L 
promoted recovery of AJ function after the thrombin chal-
lenge, in contrast to FoxM1-deficient HMVEC-L monolayers 
transfected only with siRNA (Fig. 5, A and B).
To establish the level of -catenin expression required for 
AJ recovery, we transfected various doses of plasmid DNA ex-
pressing -catenin into FoxM1 siRNA-transfected HMVEC-
L. As shown in Fig. 5 (C and D), reexpression of -catenin 
in FoxM1-deficient HMVEC-L resulted in concentration- 
dependent AJ barrier recovery. Western blot analysis con-
firmed the increases in -catenin expression (Fig. 5 E). 
Confocal microscopy showed restored membrane accumulation 
of -catenin in confluent FoxM1-deficient HMVEC-L mono-
layers transfected with plasmid DNA (Fig. 6, A and B). West-
ern blotting confirmed the increased expression of -catenin 
in the membrane fraction with little change in the cytosolic 
fraction (Fig. 6 C). In confluent EC monolayers, -catenin 
was predominantly localized at the membrane, as shown in 
Fig. 6 C (the enhanced band intensity of -catenin expression 
in the cytosolic fraction shown in Fig. 4 D is caused by the 
prolonged exposure of the signal).
To determine whether the 50% reduction in -catenin 
expression seen in FoxM1-deficient EC monolayers is suffi-
cient to impair AJ reannealing, HMVEC-L were transfected 
with 1.5 µmol/L of -catenin siRNA to achieve an 50% 
reduction in -catenin protein expression (Fig. 7, A and B). 
After transfection with either 1.5 µmol/L -catenin siRNA 
or scRNA, HMVEC-L were plated at confluent density on 
gold electrodes to measure TER. These monolayers exhib-
ited similar basal AJ barrier function at 48 h after transfection 
(Fig. 7 C). Upon challenge of monolayers with 4 U/ml 
thrombin, the resultant changes in TER were monitored for 
6 h. We observed similar decreases of TER in -catenin 
FoxM1 deficiency induces decreased -catenin  
expression in ECs
We  performed  quantitative  RT-PCR  analysis  to  assess   
expression of genes important for the formation of the endo-
thelial AJ complex. As shown in Fig. 4 A, only -catenin ex-
pression was decreased among the AJ components. Western 
Figure 4.  Decreased expression of -catenin in FoxM1-deficient 
ECs. (A) Quantitative RT-PCR analysis of expression of components of 
endothelial AJs. At 65 h after transfection of either FoxM1 siRNA or 
scRNA, confluent HMVEC-L were lysed for RNA isolation. mRNA levels of 
the indicated genes were quantified by quantitative RT-PCR analysis. Data 
are expressed as mean ± SD (error bars; n = 3). *, P < 0.05 versus scRNA. 
The experiment was performed three times with similar results.  
(B and C) Western blot analysis demonstrating decreased protein levels of 
-catenin in FoxM1-deficient HMVEC-L. At 65 h after transfection with 
either human FoxM1 siRNA (siRNA) or scRNA, confluent HMVEC-L were 
lysed for Western blot analysis of each protein. Anti-actin was used as a 
loading control (B). The experiment was performed three times with simi-
lar results. -catenin expression was quantified by densitometry analysis 
(C). Data are expressed as mean ± SD (error bars; n = 3 independent ex-
periments). *, P < 0.05 versus scRNA. (D and E) Subcellular localization of 
endothelial AJ proteins at baseline and after thrombin challenge. At 65 h 
after transfection, confluent HMVEC-L monolayers were collected for cell 
fractionation. Each membrane (M) or cytosolic (C) fraction (7.5 µg per 
lane) was loaded for detection of each protein (D). The experiment was 
performed three times with similar results. -catenin localization in the 
membrane fraction versus cytosolic fraction was quantified by densitom-
etry (E). Data are expressed as mean ± SD (error bars; n = 3 independent 
experiments). *, P < 0.01 versus membrane expression at time 0 (basal);  
#, P < 0.05 versus cytosolic expression at time 0; ƒ, P < 0.05 versus 
scRNA-membrane expression at time 0.JEM VOL. 207, August 2, 2010 
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in a marked decrease in FoxM1-binding to promoter regions 
of the human ctnnb1 gene.
To  determine  whether  FoxM1-binding  sites  are  tran-
scriptionally active, a luciferase reporter assay was performed 
with constructs driven by a human ctnnb1 promoter contain-
ing various deletions. As shown in Fig. 8 C, constructs a and 
b containing FoxM1-binding sites drove greater luciferase 
activity in subconfluent cells compared with confluent cells, 
which is consistent with the protein levels of FoxM1 in these 
conditions (Fig. 8 D). A construct with deletion of the two 
FoxM1-binding sites (construct c) abolished transcription   
activity in both confluent and subconfluent conditions. These 
data demonstrate that -catenin as a transcriptional target   
of FoxM1.
Restoration of -catenin expression in FoxM1 CKO lungs 
rescues the defective endothelial AJ reannealing phenotype
To determine whether genetic deletion of FoxM1 in EC 
monolayers  induces  decreased  -catenin  expression,  lung 
microvascular ECs and fibroblasts (used for comparison pur-
pose)  were  isolated  from  WT  and  FoxM1  CKO  lungs,   
respectively. As shown in Fig. 9 A, FoxM1 deficiency in EC 
sdown-regulated -catenin expression only in ECs. The pro-
tein level of -catenin was reduced 30% in FoxM1 CKO 
lungs compared with WT (Fig. 9 B). Interestingly, increased 
expression  of  -catenin  (plakoglobin)  and  catenin-d2   
was observed in FoxM1-deficient ECs (Fig. 9 A). We next 
siRNA-transfected cells compared with scRNA-transfected 
cells. However, -catenin siRNA-transfected cells failed to 
regain baseline values, whereas scRNA-transfected monolay-
ers recovered within 3 h of the thrombin challenge (Fig. 7 C). 
Collectively,  these  data  demonstrate  the  causal  role  of   
-catenin reduction in FoxM1-deficient EC monolayers in 
the mechanism of defective AJ barrier reannealing.
-catenin is a transcriptional target of FoxM1
FoxM1 regulates transcription of a set of genes essential for 
cell cycle progression (Kalinichenko et al., 2004; Costa, 2005; 
Laoukili et al., 2005; Wang et al., 2005; Wierstra and Alves, 
2007). FoxM1 binding to the consensus site (TTTGTTT-
GTTTT) activates transcription of these genes. We identified 
two potential FoxM1-binding sites in the 6-kb promoter re-
gion of the human ctnnb1 gene (Fig. 8 A). To determine 
whether FoxM1 binding activates transcription of the ctnnb1 
gene, we used a chromatin immunoprecipitation (ChIP) 
assay. The cross-linked and sonicated chromatin from FoxM1 
siRNA-transfected HMVEC-L was immunoprecipitated 
with either anti-FoxM1 or control IgG antibodies. Chroma-
tin from either scRNA- or mock-transfected HMVEC-L 
was used as a control. FoxM1-bound -catenin promoter 
DNA associated with immunoprecipitated chromatin was 
quantified by quantitative real-time PCR analysis with prim-
ers specific for the potential FoxM1 binding sites. As shown 
in Fig. 8 B, siRNA-mediated knockdown of FoxM1 resulted 
Figure 5.  Rescue of defective reanneal-
ing of endothelial AJ barrier of FoxM1-
deficient ECs by restoration of -catenin 
protein. (A and B) Decreased -catenin 
expression is responsible for impaired rean-
nealing of the endothelial AJ barrier in 
FoxM1-deficient HMVEC-L. HMVEC-L were 
transfected with human FoxM1 scRNA, siRNA, 
and siRNA plus plasmid DNA expressing 
human -catenin (siRNA+-cat). At 65 h after 
transfection, the monolayers were challenged 
with 4 U/ml thrombin, and TER was recorded 
for 3 h. Data are expressed as mean ± SD 
(error bars; n = 3 independent experiments).  
*, P < 0.05 versus scRNA. (C and D) -catenin 
expression rescued defective reannealing of 
the endothelial AJ barrier of FoxM1-deficient 
HMVEC-L in a dose-dependent manner.  
HMVEC-L were transfected with either FoxM1 
scRNA, siRNA, or siRNA plus plasmid DNA 
expressing human -catenin at the indicated 
amounts. At 65 h after transfection, mono-
layers were challenged with 4 U/ml thrombin, 
and TER was recorded for 3 h. Data are ex-
pressed as mean ± SD (error bars; n = 3 inde-
pendent experiments). *, P < 0.05 versus 
scRNA. (E) Western blots demonstrating in-
creased -catenin expression in FoxM1- 
deficient HMVEC-L by plasmid DNA 
transfection. The experiment was performed 
three times with similar results.1680 FoxM1 regulates endothelial AJ re-annealing | Mirza et al.
human ctnnb1 gene and control its transcription. Thus,   
-catenin  is  a  transcriptional  target  of  FoxM1  whereby 
FoxM1 regulates formation of endothelial AJ assembly.
Endothelial repair after vascular injury is a crucial process 
required for vascular homeostasis in inflammatory disorders. 
Endothelial barrier repair involves endothelial regeneration 
through FoxM1 activation of cell proliferation (Zhao et al., 
2006). As the present results show, the repair also involves 
FoxM1-induced activation of -catenin transcription, which 
results in the reannealing of AJs to form the characteristic re-
strictive endothelial barrier. Our previous study demonstrated 
the critical role of FoxM1 in regulating endothelial regenera-
tion after lung vascular injury (Zhao et al., 2006). We showed 
that mice with EC-restricted disruption of FoxM1 exhibited 
long-lived increase of lung microvessel permeability and lung 
edema formation after LPS challenge. FoxM1 deficiency se-
verely  impaired  endothelial  proliferation  in  FoxM1  CKO 
lungs (Zhao et al., 2006). However, it was not clear whether 
FoxM1 can also regulate the actual reannealing of AJs to form 
the endothelial barrier. To address the process of AJ reanneal-
ing, we used the model of PAR-1 activation, which is 
known to disassemble AJs within 30 min (Birukova et al., 2004;   
Broman et al., 2006; Zhao et al., 2010) and increase the permea-
bility of vessels (Coughlin, 2000; Vogel et al., 2000; Mehta 
and Malik, 2006, Camerer et al., 2006; Tauseef et al., 2008). 
We observed that FoxM1 CKO lung microvessels exhibited 
sustained leakage as determined by Kf,c increases after PAR-1 
activation, whereas either microvessel permeability at base-
line or a maximal increase in permeability in response to 
PAR-1 activation was similar in FoxM1 CKO and WT lungs. 
addressed whether restoration of the -catenin protein level 
in FoxM1 CKO lungs would result in the normalization of 
AJ reannealing. As shown in Fig. 9 B, liposome-mediated 
transduction of plasmid DNA expressing -catenin restored 
the protein expression of -catenin in FoxM1 CKO mouse 
lungs. At 40 h after transduction, these mice were challenged 
with a PAR-1 agonist peptide (i.v., 5 mg/kg body weight 
[BW]). Lungs were isolated at 2 h after challenge and per-
fused for Kf,c measurements. In contrast to the Kf,c value in 
control FoxM1 CKO lungs, restoration of -catenin pro-
tein expression in FoxM1 CKO lungs resulted in a Kf,c value 
similar to WT lungs (Fig. 9 C); thus, AJ reannealing of   
endothelial barrier in FoxM1 CKO lungs was restored by 
-catenin expression.
DISCUSSION
We have identified here the novel role of the transcription 
factor FoxM1 in regulating the reannealing of endothelial AJs 
through the transcriptional control of -catenin expression. 
FoxM1 CKO lungs exhibited defective reannealing of endo-
thelial barrier phenotype after AJ disruption induced by 
PAR-1 activation. FoxM1 deficiency in EC monolayers im-
paired AJ reannealing after activation of PAR-1 signaling.   
-catenin  expression  was  markedly  decreased  in  FoxM1- 
deficient EC monolayers, whereas reexpression of -catenin 
rescued the defective AJ reannealing phenotype in both EC 
monolayers and FoxM1 CKO lung vessels. Knockdown of 
-catenin  mimicked  the  phenotype  of  defective  barrier   
recovery seen in FoxM1-deficient ECs. We also show that 
FoxM1 specifically binds to the promoter regions of the   
Figure 6.  Decreased membrane expres-
sion of -catenin in confluent FoxM1-
deficient ECs. (A) Representative 
micrographs of immunofluorescent staining 
with anti–-catenin antibody. At 65 h after 
transfection with either human FoxM1 scRNA, 
siRNA, or siRNA plus plasmid DNA expressing 
human -catenin (siRNA+-catenin,  
1.5 µg/106 cells), monolayers were fixed and 
immunostained with anti–-catenin antibody 
to visualize -catenin (red). Nuclei were 
counterstained with DAPI (blue). The experi-
ment was performed three times with similar 
results. Bar, 20 µm. (B) Quantification of fluo-
rescent intensity demonstrating reduced 
membrane expression of -catenin in FoxM1-
deficient HMVEC-L, which was restored by 
exogenous -catenin expression. Accumula-
tion of -catenin at the membrane was 
quantified using 12-bit depth confocal  
z-series images. Maximum pixel values from 
different z sections were projected to a single 
plane using MetaMorph 7.1.0. Integrated fluorescence intensity of threshold projected images was calculated for -catenin. Data are expressed as mean ±  
SD (error bars; n = 3 independent experiments). *, P < 0.05 versus scRNA. **, P < 0.01 versus siRNA. (C) Western blot analysis demonstrating decreased 
-catenin protein levels in the membrane fraction in confluent FoxM1-deficient HMVEC-L. At 65 h after transfection, confluent HMVEC-L monolayers were 
collected for cell fractionation. Each membrane fraction or cytosolic fraction (7.5 µg per lane) was loaded for detection of -catenin with anti–-catenin 
antibody. The experiment was performed three times with similar results.JEM VOL. 207, August 2, 2010 
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In primary culture of HMVEC-L, FoxM1 deficiency in-
duced  by  siRNA  also  prevented  the  reannealing  of  AJs. 
These data collectively demonstrate the important role of 
FoxM1 in regulating reannealing of endothelial junctions 
after AJ disruption.
Figure 7.  Knockdown of -catenin mimics the defective reanneal-
ing phenotype of endothelial junctions seen in FoxM1-deficient 
monolayers after PAR-1 activation. (A and B) siRNA dose response of 
knockdown of -catenin. At 48 h after transfection with -catenin 
scRNA, or siRNA at indicated doses, the confluent HMVEC-L were lysed 
for Western blot analysis of -catenin protein levels. The same membrane 
was blotted with anti-actin for loading control (A). The experiment was 
performed three times with similar results. Densitometry was used to 
quantify the protein levels of -catenin under each condition (B). Data 
are expressed as mean ± SD (error bars; n = 3 independent experiments). 
*, P < 0.05 versus scRNA. 1.5 µmol/L of -catenin siRNA induces 50% 
knockdown of -catenin protein level. (C) TER assay demonstrating that 
partial knockdown of -catenin results in impaired recovery of endothe-
lial AJ function after thrombin challenge. HMVEC-L transfected with ei-
ther human -catenin siRNA (siRNA, 1.5 µmol/L) or scRNA were plated on 
electrodes at confluency. At 48 h after transfection, TER of each mono-
layer at baseline was recorded and monitored for 6 h after the thrombin 
challenge (4 U/ml). The TER value of each monolayer was normalized to 
its value at baseline. Data are expressed as mean ± SD (error bars; n = 3 
independent experiments). *, P < 0.05 versus scRNA.
Figure 8.  FoxM1 regulation of -catenin transcription. (A) Sche-
matic drawing of the 6-kb promoter region of the human ctnnb1 gene. 
FoxM1 binding sites are indicated (open box); the first exon is also show 
(shaded box). The three luciferase reporter constructs with various deletions 
of FoxM1 binding sites are also shown. (B) ChIP assay demonstrating that 
FoxM1 directly binds to two promoter regions of the ctnnb1 gene. Cross-
linked chromatin from either mock-transfected or FoxM1 siRNA- or scRNA- 
transfected HMVEC-L was immunoprecipitated with either anti-FoxM1 
antibody or IgG control. After immunoprecipitation, genomic DNA was 
analyzed for the amount of ctnnb1 promoter DNA using quantitative real-
time PCR with primers specific for each region. FoxM1 binding to genomic 
DNA was normalized to IgG control. Data are shown as mean ± SD (error 
bars; n = 3 independent experiments). *, P < 0.05 versus either mock or 
scRNA. (C) Luciferase reporter assay demonstrating that FoxM1 induced the 
transcriptional activity of the human ctnnb1 gene. After transfection with 
either luciferase reporter constructs under the control of a promoter of the 
human ctnnb1 gene with indicated deletions (a, b, and c) or empty vector 
(vector), HMVEC-L were plated at subconfluent (40%) or confluent condi-
tions. At 40 h after transfection, the cells were collected for analysis of 
luciferase activity. Data are expressed as mean ± SD (error bars; n = 3 inde-
pendent experiments). *, P < 0.05 versus either construct a or b at a conflu-
ent condition; #, P < 0.01 confluent versus subconfluent conditions; **, P < 
0.005 versus either construct a or b at a subconfluent condition. (D) West-
ern blot analysis demonstrating markedly decreased FoxM1 expression in 
confluent HMVEC-L. Cell lysates of HMVEC-L at 100% confluency and  
50–70% confluency were used for Western blotting of FoxM1 expression. 
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expression. These observations support the identified role of   
-catenin in mediating the integrity of the endothelial AJ barrier 
(Navarro et al., 1995; Carmeliet et al., 1999; Huber et al., 2001; 
Cattelino et al., 2003).
FoxM1 regulates transcription of a set of genes required 
for cell cycle progression (Kalinichenko et al., 2004; Costa, 
2005; Laoukili et al., 2005; Wang et al., 2005; Wierstra and 
Alves, 2007). Our results show that FoxM1 also regulates the 
transcription of -catenin required for the integrity of endo-
thelial AJs. FoxM1 binding to the ctnnb1 promoter activated 
the transcription of -catenin. We showed that the decreased 
-catenin  expression  in  FoxM1-deficient  EC  monolayers 
was the result of a loss of FoxM1-mediated transcription. 
These data identify a novel mechanism of repair of endothe-
lial AJs through FoxM1-mediated transcription of -catenin–
mediating  reannealing  of  endothelial  AJs  and  endothelial 
barrier repair.
Given that FoxM1 was shown to regulate the transcrip-
tion of the -catenin gene and endothelial AJ barrier func-
tion, it would be expected that FoxM1 CKO vessels should 
have increased basal vascular permeability values. However, 
we observed that these values were normal in FoxM1 CKO 
lungs. This apparent discrepancy can be ascribed to genetic 
compensation, perhaps on the basis of expression of other   
AJ protein constituents. We observed increased expression of 
-catenin and catenin-d2 in FoxM1-deficient ECs isolated 
from FoxM1 CKO lungs, which may maintain basal permeabil-
ity at a relatively normal set point despite the reduction in   
-catenin expression in FoxM1-deficient ECs. It has been 
shown that -catenin can take over the role of -catenin in 
cell adhesion and preserve intact AJs in -catenin–deficient 
embryos (Huelsken et al., 2000). Another possible explana-
tion is that the remaining pool of -catenin protein is suffi-
cient to seal the endothelial barrier. However, in the acute 
response to PAR-1 activation, any defects in -catenin expres-
sion may be sufficient to impair reannealing of the endothelial 
barrier. Our studies provide unequivocal evidence that FoxM1-
regulated -catenin expression plays a crucial role in regulating 
the reannealing of endothelial AJs to reform the characteristic 
restrictive endothelial barrier after vascular injury.
In conclusion, the rapid restoration of the restrictive en-
dothelial barrier is critical for vascular homeostasis, and the 
lack of full recovery of AJ barrier function can lead to chronic 
inflammation. This study shows the obligatory role of FoxM1 
in regulating the reannealing of endothelial AJs through tran-
scriptional control of -catenin expression. We have demon-
strated that FoxM1 regulates endothelial repair by not only 
inducing endothelial regeneration as shown (Zhao et al., 
2006) but also in a more rapid manner by reforming and   
resealing the AJ endothelial barrier through expression of   
-catenin. Thus, promotion of FoxM1-mediated endothelial 
regeneration and reannealing of endothelial AJs may rep-
resent a novel means of endothelial repair and restoring 
vascular homeostasis, and thereby preventing inflamma-
tory diseases associated with persistently leaky vessels such 
as acute lung injury.
Figure 9.  Normalization of the endothelial AJ barrier by restora-
tion of -catenin expression after increased vascular permeability 
in FoxM1 CKO lungs. (A) Quantitative RT-PCR analysis of gene expres-
sion. After 2 d in culture, microvascular ECs isolated from WT or FoxM1 
CKO mouse lungs were lysed for total RNA isolation. Non-EC cultures 
(fibroblasts) were also lysed for total RNA isolation. mRNA levels of the 
indicated genes were quantified by quantitative RT-PCR. Data are ex-
pressed as mean ± SD (error bars; n = 3 independent experiments). *, P < 
0.01 versus WT-EC; #, P < 0.05 versus WT-EC. (B) Western blotting dem-
onstrating decreased -catenin expression in FoxM1 CKO lungs compared 
with WT lungs and restoration of -catenin expression by liposome- 
mediated transduction of plasmid DNA expressing -catenin. The experi-
ment was performed three times with similar results. CKO, FoxM1 CKO.  
(C) Normalization of vascular junctional repair by restoration of -catenin 
expression in FoxM1 CKO lungs. Plasmid DNA expressing -catenin or 
empty vector were transduced in FoxM1 CKO lungs through i.v. injection 
of the liposome–DNA complex. WT mice transduced with empty vector 
DNA were used as controls. At 40 h after transduction, mice were chal-
lenged with a PAR-1 agonist peptide (i.v., 5 mg/kg BW). Lungs were iso-
lated at 2 h after challenge and perfused for Kf,c measurement. Data are 
expressed as mean ± SD (error bars; n = 3–4 animals/group from three 
independent experiments). *, P < 0.05 versus either WT + vector, or CKO + 
-catenin.
We observed a marked decrease in plasma membrane ex-
pression  of  -catenin  in  FoxM1-deficient  EC  monolayers, 
whereas expression of other components of AJs (VE-cadherin, 
-catenin,  and  p120-catenin)  was  not  significantly  affected. 
Importantly, expression of -catenin in FoxM1-deficient   
EC monolayers rescued the defective AJ reannealing pheno-
type after PAR-1 activation. A 50% reduction of -catenin in 
EC monolayers induced by siRNA mimicked the pheno-
type of defective AJ reannealing seen in FoxM1-deficient 
ECs, in which there was also a 50% reduction in -catenin JEM VOL. 207, August 2, 2010 
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Molecular analysis. Total RNA was isolated using an RNeasy Mini kit includ-
ing DNase I digestion (Qiagen), and one-step quantitative RT-PCR analysis 
was performed with a sequence detection system (ABI Prism 7000; Applied Bio-
systems) with a QuantiTect SYBR Green PCR kit (QIAGEN). The following 
primers were used for analyses: human FoxM1 primers, 5-GGAGGAAATGC-
CACACTTAGCG-3 and 5-TAGGACTTCTTGGGTCTTGGGGTG-3;   
human -catenin primers, 5-CAAGTGGGTGGTATAGAGG-3 and 
5-TCAATGGGAGAATAAAGCAGC-3; human VE-cadherin primers, 
5-TCGCTGTTGTCACATCTCAGGGAA-3  and  5-TGACTGAT-
GCCACTTCTCCAAGGT-3;  human  18S  ribosomal  RNA  (rRNA), 
5-TTCCGACCATAAACGATGCCGA-3and  5-GACTTTGGTTT-
CCCGGAAGCTG-3; mouse FoxM1 primers, 5-CACTTGGATTGAGG-
ACCACTT-3 and 5-GTCGTTTCTGCTGTGATTCC-3; and mouse 
cyclophilin primers, 5-CTTGTCCATGGCAAATGCTG-3 and 5-TGA-
TCTTCTTGCTGGTCTTGC-3.  Primers  for  human  p120-catenin  and 
-catenin, and for mouse -catenin, -catenin, and catenin-d2 were obtained 
from QIAGEN. All human gene expression was normalized to human 18S 
rRNA as an internal control, whereas mouse FoxM1 expression was normal-
ized to mouse cyclophilin as an internal control.
Western blot analyses were performed using antibodies against -catenin 
(1:200), VE-cadherin (1:1,000), -catenin (1:200), p120-catenin (1:200), 
and  FoxM1  (1:1,000),  respectively.  All  antibodies  were  purchased  from 
Santa Cruz Biotechnology, Inc. The same blot was reprobed with anti-actin 
mAb (1:3,500; BD) for loading control.
Transendothelial monolayer electrical resistance. Real-time change   
in endothelial monolayer resistance was measured using the ECIS system 
(Applied Biophysics) to assess endothelial barrier function (Tiruppathi et al., 
1992). In brief, after transfection, HMVEC-L were plated at confluence on 
a small gold electrode precoated with 0.2% gelatin. The small electrode and 
the larger counter electrode were connected to a phase-sensitive lock-in 
amplifier. An approximate constant current of 1 µA was supplied by a 1-V, 
4,000-Hz alternating current signal connected serially to a 1-MΩ resistor be-
tween the small electrode and the larger counter electrode. The voltage be-
tween the small electrode and the large electrode was monitored by a lock-in 
amplifier, stored, and processed with a computer. The same computer con-
trolled the output of the amplifier and switched the measurement to differ-
ent electrodes in the course of an experiment. Before the experiment, the 
confluent endothelial monolayer was kept in 0.5% FBS-containing medium 
for 2 h. After 30–60 min of recording the TER at baseline, the endothelial 
monolayers were challenged with 4 U/ml of human -thrombin (Enzyme 
Research  Laboratories),  and  thrombin-induced  change  in  resistance  was 
monitored up to 13 h after the thrombin challenge.
Imaging. HMVEC-L were fixed with 4% paraformaldehyde and stained 
with anti–VE-cadherin (1:1,000; Sigma-Aldrich), or anti–-catenin (1:200; 
Sigma-Aldrich). Nuclei were counterstained with DAPI. Cells were imaged 
with a confocal microscope system (LSM 510; Carl Zeiss, Inc.) equipped 
with a 63× 1.2 NA objective lens (Carl Zeiss, Inc.). The relative accumula-
tion of -catenin at AJs was quantified using 12-bit depth confocal z-series 
images. The maximum pixel values from different z sections were projected 
to the single plane using MetaMorph 7.1.0 software (MDS Analytical Tech-
nologies), and the integrated fluorescence intensity of threshold projected 
images was calculated for -catenin. The values of the intensity threshold 
were selected using images of control untreated cells, and these values were 
retained for image analysis of samples from all experimental conditions. The 
integrated fluorescence intensities for -catenin were plotted as median ± 
SD. The area of intercellular AJ gaps was quantified using MetaMorph 7.1.0 
by manually outlining cells and selecting for gaps. The values are expressed 
as a percentage of the total surface area.
Liposome-mediated  gene  transfer.  Liposomes  were  prepared  as  de-
scribed previously (Bachmaier et al., 2007). In brief, the mixture, consisting 
of dimethyldioctadecylammonium bromide and cholesterol (1:1 molar 
ratio), was dried using the Rotavaporator (Brinkmann) and dissolved in 
MATERIALS AND METHODS
Mice. The generation of mice with EC-specific inactivation of  FoxM1 
(FoxM1 CKO) has been described previously (Zhao et al., 2006). Littermates 
of genotypes of FoxMfl/fl from the same breeding pair were used as WT, 
whereas FoxM1fl/fl and Cre were used as FoxM1 CKO. All mice were bred 
and maintained in the Association for Assessment and Accreditation of Labo-
ratory Animal Care–accredited animal facilities at the University of Illinois at 
Chicago according to National Institutes of Health guidelines. All animal 
experiments were performed in accordance with protocols approved by the 
University of Illinois at Chicago Animal Care and Use Committee.
Pulmonary microvascular permeability. Microvessel Kf,c was mea-
sured to determine the pulmonary microvascular permeability to liquids, as 
described previously (Vogel et al., 2000; Tiruppathi et al., 2002). In brief, 
after standard 30-min equilibration perfusion, the outflow pressure was 
rapidly elevated by 13 cm H2O for 20 min and then returned to normal. 
The changes of lung wet weight reflect net fluid extravasation. At the end 
of each experiment, lungs were dissected free of nonpulmonary tissue, and 
lung dry weight was determined. Kf,c (ml/min/cmH2O/dry weight [g]) 
was calculated from the slope of the recorded weight change normalized to 
the  pressure  change  and  to  lung  dry  weight.  PAR-1  agonist  peptide 
(TFLLRN-NH2; Vogel et al., 2000; Tauseef et al., 2008) was adminis-
tered via jugular vein injection, and lungs were isolated at various times for 
Kf,c measurement.
Primary  cultures  of  lung  microvascular  ECs.  Primary  cultures  of   
HMVEC-L (Lonza) were cultured in T75 flasks precoated with 0.2% gelatin 
in EBM-2 complete medium supplemented with 15% FBS and EGM-2 MV 
Singlequots (Lonza), and maintained at 37°C in a humidified atmosphere of 
5% CO2 and 95% air. The cells were used for experiments between four and 
seven passages. To express -catenin in HMVEC-L, human cDNA of   
-catenin was cloned into expression vector pcDNA3.1 (provided by E.R. 
Fearon, University of Michigan Medical School, Ann Arbor, MI) and trans-
fected into HMVEC-L using the HMVEC-L Nucleofector kit with the 
Amaxa Nucleofector device (Lonza).
Primary cultures of mouse lung microvascular ECs were established   
using cells immuno-selected from mouse lungs as described previously (Zhao 
et al., 2006). In brief, a cell suspension was prepared from lungs by digestion 
with 1 mg/ml collagenase and 0.5 mg/ml dispase for 30 min twice, followed 
by filtration using 70-µm and 40-µm nylon filters. ECs were then selected 
using a rat antibody to mouse CD-31 (Millipore) and a secondary antibody 
coupled to magnetic beads (Miltenyi Biotec). Purified ECs were plated on a 
0.2% gelatin-coated T25 flask followed by a medium change on the second 
day. ECs were lysed for total RNA isolation after growing 2 d in EBM-2 
complete medium (Lonza). Primary cultures of fibroblasts were established 
by collecting cells from the EC-depleted flow-through of the magnetic col-
umn and plating directly on T75 flask in DMEM made with 10% FBS (Invi-
trogen). Confluent cultures of these non-ECs were then trypsinized and 
replated. After four passages, these primary cultures of fibroblast-enriched 
non-ECs were used for experiments as controls.
siRNA-mediated gene knockdown. Both FoxM1 siRNA and scRNA 
were synthesized (Integrated DNA Technology) based on previously pub-
lished sequences (Wang et al., 2005). The human -catenin siRNA sequences 
are  as  follows:  5-GUAGCUGAUAUUGAUGGACTT-3  and  5-GU-
CCAUCAAUAUCAGCUACTT-3.  The  following  human  -catenin 
scRNA sequences were used for controls: 5-GUAUUGGCUGAUAAU-
ACGGTT-3 and 5-CCGUAUUAUCAGCCAAUAC-3. Transfection of 
either siRNA or scRNA was performed using the HMVEC-L Nucleofector 
kit (Lonza) according to the manufacturer’s instructions. In brief, HMVEC-L 
cells grown to 90% confluence were trypsinized, pelleted, and resuspended 
in 100 µl of HMVEC-L nucleofector solution with 4 µl (2, 3, and 4 µl for 
-catenin knockdown) of 50 µmol/L siRNA or scRNA. Cells were rapidly 
electroporated with an Amaxa Nucleofector device (Lonza), and then plated 
in EBM-2 complete medium for experiments.1684 FoxM1 regulates endothelial AJ re-annealing | Mirza et al.
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5% glucose followed by 20 min of sonication. The complex consisting of   
plasmid DNA (empty vector, or expressing -catenin) and liposomes was 
combined at the ratio of 1 µg of DNA to 8 nmol of liposomes. The DNA– 
liposome complex (50 µg of DNA/mouse) was injected into the retro- 
orbital venous plexus.
ChIP assay. FoxM1-depleted or control HMVEC-L at 65 h after transfection 
were processed for a ChIP assay with a ChIP assay kit (Millipore) according to 
the manufacturer’s instructions. In brief, HMVEC-L transfected with either 
FoxM1 siRNA or scRNA, or mock transfected, were cross-linked in situ by 
incubation with 1% formaldehyde at 37°C for 10 min, and sonicated (550 
Sonic Dismembrator; Thermo Fisher Scientific) to generate DNA fragments 
at 500–1,000 bp. For the immunoprecipitation, 10 µg of anti-FoxM1 antibody 
(Santa Cruz Biotechnology) or control IgG were added to 300 µg of pre-
cleared DNA sample and incubated overnight at 4°C with rotation. After serial 
washes, cross-links of DNA samples were reversed by incubation at 65°C for 
4 h, and then isolated for quantitative real-time PCR analysis. PCR analysis 
was performed with a sequence detection system (ABI Prism 7000) using the 
following primers specific to the regulatory regions of the human ctnnb1 gene: 
5,739 bp upstream site, 5-AAACTTTACAATTTGGCCATGAG-3 and 
5-GGTAAGGACGTAGTCATTTCTG-3;  and  3,016  bp  upstream  site,   
5-AGCCAACCATGTAGTCTGACAAG-3  and  5-ACTTGGACTC-
TACATCCGAATC-3.  DNA  binding  was  normalized  to  control  ChIP 
DNA samples immunoprecipitated with control rabbit serum.
Statistical analysis. The Student’s t test and analysis of variance test were 
used to determine statistical significance. P-values < 0.05 denote the pres-
ence of a statistically significant difference.
Online supplemental material. Fig. S1 shows the absolute TER value, 
demonstrating impaired re-annealing of endothelial barrier in FoxM1- 
deficient HMVEC-L after the thrombin challenge. Fig. S2 demonstrates de-
fective recovery of endothelial barrier in FoxM1-deficient EC monolayers 
after a challenge with histamine, which suggests that the defective AJ barrier 
recovery response was not mediator specific. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20091857/DC1.
This work was supported by National Institutes of Health grant R01 HL085462 to 
Y.Y. Zhao. We thank Dr. Eric R. Fearon from the Department of Internal Medicine, 
University of Michigan Medical School, for his generosity in providing us the 
plasmid DNA expressing human -catenin. We appreciate Drs. Yulia Komarova and 
Oleg Chaga from the Department of Pharmacology, University of Illinois at Chicago 
for their expert support with confocal microscopy imaging.
The authors have no conflicting financial interests.
Submitted: 28 August 2009
Accepted: 16 June 2010
REFERENCES
Aberle,  H.,  H.  Schwartz,  and  R.  Kemler.  1996.  Cadherin-catenin  com-
plex:  protein  interactions  and  their  implications  for  cadherin  function.   
J.  Cell.  Biochem.  61:514–523.  doi:10.1002/(SICI)1097-4644(19960616)61: 
4<514::AID-JCB4>3.0.CO;2-R
Aird, W.C. 2007. Phenotypic heterogeneity of the endothelium: I. Structure, 
function, and mechanisms. Circ. Res. 100:158–173. doi:10.1161/01 
.RES.0000255691.76142.4a
Bachmaier, K., S. Toya, X. Gao, T. Triantafillou, S. Garrean, G.Y. Park, 
R.S. Frey, S. Vogel, R. Minshall, J.W. Christman, et al. 2007. E3 ubiq-
uitin ligase Cblb regulates the acute inflammatory response underlying 
lung injury. Nat. Med. 13:920–926. doi:10.1038/nm1607
Bazzoni, G., and E. Dejana. 2004. Endothelial cell-to-cell junctions: mo-
lecular organization and role in vascular homeostasis. Physiol. Rev. 
84:869–901. doi:10.1152/physrev.00035.2003
Birukova, A.A., K. Smurova, K.G. Birukov, K. Kaibuchi, J.G. Garcia, and 
A.D. Verin. 2004. Role of Rho GTPases in thrombin-induced lung 
vascular endothelial cells barrier dysfunction. Microvasc. Res. 67:64–77. 
doi:10.1016/j.mvr.2003.09.007JEM VOL. 207, August 2, 2010 
Article
1685
increase in pulmonary microvascular permeability in PAR-1 knockout 
mice. Physiol. Genomics. 4:137–145.
Wang, I.C., Y.J. Chen, D. Hughes, V. Petrovic, M.L. Major, H.J. Park, Y. 
Tan, T. Ackerson, and R.H. Costa. 2005. Forkhead box M1 regulates 
the transcriptional network of genes essential for mitotic progression and 
genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol. Cell. Biol. 
25:10875–10894. doi:10.1128/MCB.25.24.10875-10894.2005
Ware,  L.B.,  and  M.A.  Matthay.  2000.  The  acute  respiratory  dis-
tress  syndrome.  N.  Engl.  J.  Med.  342:1334–1349.  doi:10.1056/ 
NEJM200005043421806
Weis,  S.M.,  and  D.A.  Cheresh.  2005.  Pathophysiological  consequences 
of  VEGF-induced  vascular  permeability.  Nature.  437:497–504.  doi: 
10.1038/nature03987
Wierstra, I., and J. Alves. 2007. FOXM1, a typical proliferation-associated tran-
scription factor. Biol. Chem. 388:1257–1274. doi:10.1515/BC.2007.159
Zhao,  Y.Y.,  X.P.  Gao,  Y.D.  Zhao,  M.K.  Mirza,  R.S.  Frey,  V.V. 
Kalinichenko,  I.C.  Wang,  R.H.  Costa,  and  A.B.  Malik.  2006. 
Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair   
following LPS-induced vascular injury. J. Clin. Invest. 116:2333–2343. 
doi:10.1172/JCI27154
Zhao, Y.D., H. Ohkawara, S.M. Vogel, A.B. Malik, and Y.Y. Zhao. 2010. 
Bone marrow-derived progenitor cells prevent thrombin-induced in-
crease in lung vascular permeability. Am. J. Physiol. Lung Cell. Mol. 
Physiol. 298:L36–L44. doi:10.1152/ajplung.00064.2009
Mehta, D., and A.B. Malik. 2006. Signaling mechanisms regulating endo-
thelial  permeability.  Physiol.  Rev.  86:279–367.  doi:10.1152/physrev 
.00012.2005
Navarro, P., L. Caveda, F. Breviario, I. Mândoteanu, M.G. Lampugnani, 
and E. Dejana. 1995. Catenin-dependent and -independent functions of   
vascular endothelial cadherin. J. Biol. Chem. 270:30965–30972. doi:10 
.1074/jbc.270.52.30965
Tauseef,  M.,  V.  Kini,  N.  Knezevic,  M.  Brannan,  R.  Ramchandaran, 
H.  Fyrst,  J.  Saba,  S.M.  Vogel,  A.B.  Malik,  and  D.  Mehta.  2008. 
Activation of sphingosine kinase-1 reverses the increase in lung vas-
cular permeability through sphingosine-1-phosphate receptor signal-
ing  in  endothelial  cells.  Circ.  Res.  103:1164–1172.  doi:10.1161/01 
.RES.0000338501.84810.51
Tiruppathi, C., A.B. Malik, P.J. Del Vecchio, C.R. Keese, and I. Giaever. 
1992. Electrical method for detection of endothelial cell shape change 
in real time: assessment of endothelial barrier function. Proc. Natl. Acad. 
Sci. USA. 89:7919–7923. doi:10.1073/pnas.89.17.7919
Tiruppathi, C., M. Freichel, S.M. Vogel, B.C. Paria, D. Mehta, V. Flockerzi, 
and A.B. Malik. 2002. Impairment of store-operated Ca2+ entry in 
TRPC4(-/-) mice interferes with increase in lung microvascular per-
meability.  Circ.  Res.  91:70–76.  doi:10.1161/01.RES.0000023391 
.40106.A8
Vogel, S.M., X. Gao, D. Mehta, R.D. Ye, T.A. John, P. Andrade-Gordon, 
C. Tiruppathi, and A.B. Malik. 2000. Abrogation of thrombin-induced 